|
US4503035B1
(en)
|
1978-11-24 |
1996-03-19 |
Hoffmann La Roche |
Protein purification process and product
|
|
US4530901A
(en)
|
1980-01-08 |
1985-07-23 |
Biogen N.V. |
Recombinant DNA molecules and their use in producing human interferon-like polypeptides
|
|
US5231176A
(en)
|
1984-08-27 |
1993-07-27 |
Genentech, Inc. |
Distinct family DNA encoding of human leukocyte interferons
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4868103A
(en)
|
1986-02-19 |
1989-09-19 |
Enzo Biochem, Inc. |
Analyte detection by means of energy transfer
|
|
ATE108459T1
(de)
|
1986-04-22 |
1994-07-15 |
Salk Inst For Biological Studi |
Antagonisten des fibroblasten-wachstumsfaktors.
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US4843155A
(en)
|
1987-11-19 |
1989-06-27 |
Piotr Chomczynski |
Product and process for isolating RNA
|
|
GB8827305D0
(en)
|
1988-11-23 |
1988-12-29 |
British Bio Technology |
Compounds
|
|
US5468468A
(en)
|
1989-02-09 |
1995-11-21 |
The United States Of America, As Represented By The Secretary Of The Department Of Health & Human Services |
Method for making a monoclonal antibody, monoclonal antibodies to α PD
|
|
US5252725A
(en)
|
1989-06-23 |
1993-10-12 |
The Trustees Of The University Of Pennsylvania |
α-1-antichymotrypsin, analogues and methods of production
|
|
US5674685A
(en)
|
1990-06-11 |
1997-10-07 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
|
US5668264A
(en)
|
1990-06-11 |
1997-09-16 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
|
US5023264A
(en)
|
1990-07-16 |
1991-06-11 |
American Home Products Corporation |
Rapamycin oximes
|
|
US5120726A
(en)
|
1991-03-08 |
1992-06-09 |
American Home Products Corporation |
Rapamycin hydrazones
|
|
US5023263A
(en)
|
1990-08-09 |
1991-06-11 |
American Home Products Corporation |
42-oxorapamycin
|
|
US5023262A
(en)
|
1990-08-14 |
1991-06-11 |
American Home Products Corporation |
Hydrogenated rapamycin derivatives
|
|
US5378696A
(en)
|
1990-09-19 |
1995-01-03 |
American Home Products Corporation |
Rapamycin esters
|
|
US5221670A
(en)
|
1990-09-19 |
1993-06-22 |
American Home Products Corporation |
Rapamycin esters
|
|
US5130307A
(en)
|
1990-09-28 |
1992-07-14 |
American Home Products Corporation |
Aminoesters of rapamycin
|
|
US5358944A
(en)
|
1990-09-19 |
1994-10-25 |
American Home Products Corporation |
Rapamycin esters for treating transplantation rejection
|
|
US5233036A
(en)
|
1990-10-16 |
1993-08-03 |
American Home Products Corporation |
Rapamycin alkoxyesters
|
|
EP0566673A1
(en)
|
1990-12-21 |
1993-10-27 |
Creative Biomolecules, Inc. |
Biosynthetic pdgf antagonists
|
|
ES2147729T3
(es)
|
1991-01-31 |
2000-10-01 |
Cor Therapeutics Inc |
Dominios de la region extracelular de polipeptidos receptores de factor de crecimiento derivado de plaquetas humano.
|
|
GB9106678D0
(en)
|
1991-03-28 |
1991-05-15 |
Ferguson Mark W J |
Wound healing
|
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
|
US5100883A
(en)
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
|
US5118678A
(en)
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
|
US5194447A
(en)
|
1992-02-18 |
1993-03-16 |
American Home Products Corporation |
Sulfonylcarbamates of rapamycin
|
|
US5138051A
(en)
|
1991-08-07 |
1992-08-11 |
American Home Products Corporation |
Rapamycin analogs as immunosuppressants and antifungals
|
|
US5480883A
(en)
|
1991-05-10 |
1996-01-02 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
US5409930A
(en)
|
1991-05-10 |
1995-04-25 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
US5118677A
(en)
|
1991-05-20 |
1992-06-02 |
American Home Products Corporation |
Amide esters of rapamycin
|
|
US5120727A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Rapamycin dimers
|
|
US5120725A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Bicyclic rapamycins
|
|
AU732820B2
(en)
|
1995-06-02 |
2001-05-03 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to growth factors
|
|
NZ243082A
(en)
|
1991-06-28 |
1995-02-24 |
Ici Plc |
4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
|
|
US5169851A
(en)
|
1991-08-07 |
1992-12-08 |
American Home Products Corporation |
Rapamycin analog as immunosuppressants and antifungals
|
|
US5202332A
(en)
|
1991-08-07 |
1993-04-13 |
American Home Products Corporation |
Rapamycin analog as immunosuppressant
|
|
US5162333A
(en)
|
1991-09-11 |
1992-11-10 |
American Home Products Corporation |
Aminodiesters of rapamycin
|
|
FI941572L
(fi)
|
1991-10-07 |
1994-05-27 |
Oncologix Inc |
Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
|
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
|
US5164399A
(en)
|
1991-11-18 |
1992-11-17 |
American Home Products Corporation |
Rapamycin pyrazoles
|
|
US5817310A
(en)
|
1991-12-02 |
1998-10-06 |
Cor Therapeutics, Inc. |
Inhibitory immunoglobulin polypeptides to human PDGF beta receptor
|
|
US5238950A
(en)
|
1991-12-17 |
1993-08-24 |
Schering Corporation |
Inhibitors of platelet-derived growth factor
|
|
US5221740A
(en)
|
1992-01-16 |
1993-06-22 |
American Home Products Corporation |
Oxepane isomers of rapamycin useful as immunosuppressive agents
|
|
DE69326967T2
(de)
|
1992-01-17 |
2000-06-15 |
Lakowicz, Joseph R. |
Phasenmodulationsenergieübertragungsfluoroimmunassay
|
|
AU661533B2
(en)
|
1992-01-20 |
1995-07-27 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
AU675929B2
(en)
|
1992-02-06 |
1997-02-27 |
Curis, Inc. |
Biosynthetic binding protein for cancer marker
|
|
US5262424A
(en)
|
1992-02-18 |
1993-11-16 |
American Home Products Corporation |
Composition of sulfonylcarbamates of rapamycin and method of treating diseases requiring immunosuppression therewith
|
|
US5260299A
(en)
|
1992-03-05 |
1993-11-09 |
American Home Products Corporation |
Rapamycin 42-sulfonates and 42-(N-Carboalkoxy)Sulfamates Useful as Immunosuppressive Agents
|
|
US5177203A
(en)
|
1992-03-05 |
1993-01-05 |
American Home Products Corporation |
Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
|
|
TW225528B
(https=)
|
1992-04-03 |
1994-06-21 |
Ciba Geigy Ag |
|
|
US5521184A
(en)
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
|
US5821234A
(en)
|
1992-09-10 |
1998-10-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Inhibition of proliferation of vascular smooth muscle cell
|
|
US5869462A
(en)
|
1992-09-10 |
1999-02-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Inhibition of proliferation of vascular smooth muscle cell
|
|
GB9221220D0
(en)
|
1992-10-09 |
1992-11-25 |
Sandoz Ag |
Organic componds
|
|
US5434260A
(en)
|
1992-10-13 |
1995-07-18 |
American Home Products Corporation |
Carbamates of rapamycin
|
|
US5480988A
(en)
|
1992-10-13 |
1996-01-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
|
US5480989A
(en)
|
1992-10-13 |
1996-01-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
|
US5489680A
(en)
|
1992-10-13 |
1996-02-06 |
American Home Products Corporation |
Carbamates of rapamycin
|
|
US5302584A
(en)
|
1992-10-13 |
1994-04-12 |
American Home Products Corporation |
Carbamates of rapamycin
|
|
US5411967A
(en)
|
1992-10-13 |
1995-05-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
|
US5262423A
(en)
|
1992-10-29 |
1993-11-16 |
American Home Products Corporation |
Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
|
|
US6177401B1
(en)
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
|
US5260300A
(en)
|
1992-11-19 |
1993-11-09 |
American Home Products Corporation |
Rapamycin carbonate esters as immuno-suppressant agents
|
|
US5455258A
(en)
|
1993-01-06 |
1995-10-03 |
Ciba-Geigy Corporation |
Arylsulfonamido-substituted hydroxamic acids
|
|
US5620687A
(en)
|
1993-02-25 |
1997-04-15 |
Zymogenetics, Inc. |
Inhibition of intimal hyperplasia using antibodies to PDGF beta receptors
|
|
US5976534A
(en)
|
1993-02-25 |
1999-11-02 |
Zymogenetics, Inc. |
Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin
|
|
JPH08503971A
(ja)
|
1993-10-01 |
1996-04-30 |
チバ−ガイギー アクチェンゲゼルシャフト |
ピリミジンアミン誘導体及びその調製のための方法
|
|
US5378836A
(en)
|
1993-10-08 |
1995-01-03 |
American Home Products Corporation |
Rapamycin oximes and hydrazones
|
|
US5373014A
(en)
|
1993-10-08 |
1994-12-13 |
American Home Products Corporation |
Rapamycin oximes
|
|
US5391730A
(en)
|
1993-10-08 |
1995-02-21 |
American Home Products Corporation |
Phosphorylcarbamates of rapamycin and oxime derivatives thereof
|
|
US5952304A
(en)
|
1993-10-22 |
1999-09-14 |
Trigen Limited |
Platelet-derived growth factor analogues
|
|
US5656643A
(en)
|
1993-11-08 |
1997-08-12 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
|
JPH07133280A
(ja)
|
1993-11-09 |
1995-05-23 |
Takeda Chem Ind Ltd |
セフェム化合物、その製造法および抗菌組成物
|
|
US5385909A
(en)
|
1993-11-22 |
1995-01-31 |
American Home Products Corporation |
Heterocyclic esters of rapamycin
|
|
US5385908A
(en)
|
1993-11-22 |
1995-01-31 |
American Home Products Corporation |
Hindered esters of rapamycin
|
|
US5385910A
(en)
|
1993-11-22 |
1995-01-31 |
American Home Products Corporation |
Gem-distributed esters of rapamycin
|
|
US5912253A
(en)
|
1993-12-17 |
1999-06-15 |
Novartis Ag |
Rapamycin derivatives
|
|
US5389639A
(en)
|
1993-12-29 |
1995-02-14 |
American Home Products Company |
Amino alkanoic esters of rapamycin
|
|
US6271363B1
(en)
|
1993-12-30 |
2001-08-07 |
President & Fellows Of Harvard College |
Nucleic acids encoding hedgehog proteins
|
|
US5700823A
(en)
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
|
IL112248A0
(en)
|
1994-01-25 |
1995-03-30 |
Warner Lambert Co |
Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
|
|
IL112249A
(en)
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
|
US5504291A
(en)
|
1994-02-14 |
1996-04-02 |
Square D Company |
Contact blade assembly for a circuit breaker
|
|
WO1995024190A2
(en)
|
1994-03-07 |
1995-09-14 |
Sugen, Inc. |
Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
|
|
US5525610A
(en)
|
1994-03-31 |
1996-06-11 |
American Home Products Corporation |
42-Epi-rapamycin and pharmaceutical compositions thereof
|
|
US5362718A
(en)
|
1994-04-18 |
1994-11-08 |
American Home Products Corporation |
Rapamycin hydroxyesters
|
|
EP0682027B1
(de)
|
1994-05-03 |
1997-10-15 |
Novartis AG |
Pyrrolopyrimidinderivate mit antiproliferativer Wirkung
|
|
US5463048A
(en)
|
1994-06-14 |
1995-10-31 |
American Home Products Corporation |
Rapamycin amidino carbamates
|
|
US5958942A
(en)
|
1994-07-15 |
1999-09-28 |
Takeda Chemical Industries, Ltd. |
Tricyclic nitrogen ring compounds, their production and use
|
|
CA2156767A1
(en)
|
1994-08-25 |
1996-02-26 |
Kenichi Matsunaga |
Binding agent for growth factor
|
|
US5476851A
(en)
|
1994-09-08 |
1995-12-19 |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. |
Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase
|
|
US5795910A
(en)
|
1994-10-28 |
1998-08-18 |
Cor Therapeutics, Inc. |
Method and compositions for inhibiting protein kinases
|
|
US5491231A
(en)
|
1994-11-28 |
1996-02-13 |
American Home Products Corporation |
Hindered N-oxide esters of rapamycin
|
|
US5563145A
(en)
|
1994-12-07 |
1996-10-08 |
American Home Products Corporation |
Rapamycin 42-oximes and hydroxylamines
|
|
US5863949A
(en)
|
1995-03-08 |
1999-01-26 |
Pfizer Inc |
Arylsulfonylamino hydroxamic acid derivatives
|
|
MX9707453A
(es)
|
1995-03-30 |
1997-12-31 |
Pfizer |
Derivados de quinazolina.
|
|
ES2150113T3
(es)
|
1995-04-03 |
2000-11-16 |
Novartis Ag |
Derivados de pirazol y procedimientos para la preparacion de los mismos.
|
|
DK0821671T3
(da)
|
1995-04-20 |
2001-04-23 |
Pfizer |
Arylsulfonylhydroxamsyrederivater som MMP- og TNF-inhibitorer
|
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
US6331555B1
(en)
|
1995-06-01 |
2001-12-18 |
University Of California |
Treatment of platelet derived growth factor related disorders such as cancers
|
|
US5723594A
(en)
|
1995-06-07 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
|
US6229002B1
(en)
|
1995-06-07 |
2001-05-08 |
Nexstar Pharmaceuticlas, Inc. |
Platelet derived growth factor (PDGF) nucleic acid ligand complexes
|
|
US5880141A
(en)
|
1995-06-07 |
1999-03-09 |
Sugen, Inc. |
Benzylidene-Z-indoline compounds for the treatment of disease
|
|
US5618837A
(en)
|
1995-06-07 |
1997-04-08 |
Zymogenetics, Inc. |
PDGF antagonists III
|
|
US5650415A
(en)
|
1995-06-07 |
1997-07-22 |
Sugen, Inc. |
Quinoline compounds
|
|
EP0833828B1
(en)
|
1995-06-09 |
2002-11-20 |
Novartis AG |
Rapamycin derivatives
|
|
AU5938696A
(en)
|
1995-06-30 |
1997-02-05 |
Zymogenetics Inc. |
4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists
|
|
MX9800215A
(es)
|
1995-07-06 |
1998-03-31 |
Novartis Ag |
Pirrolopirimidas y procesos para su preparacion.
|
|
DK9500262U4
(da)
|
1995-07-07 |
1996-10-07 |
Bonus Energy As |
Bundramme til vindmøllehus samt vindmølle omfattende samme
|
|
BE1009856A5
(fr)
|
1995-07-14 |
1997-10-07 |
Sandoz Sa |
Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
|
|
AR004010A1
(es)
|
1995-10-11 |
1998-09-30 |
Glaxo Group Ltd |
Compuestos heterociclicos
|
|
GB9520822D0
(en)
|
1995-10-11 |
1995-12-13 |
Wellcome Found |
Therapeutically active compounds
|
|
CN1202932A
(zh)
|
1995-10-23 |
1998-12-23 |
儿童医学中心公司 |
治疗用抗血管生成的组合物和方法
|
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US5854033A
(en)
|
1995-11-21 |
1998-12-29 |
Yale University |
Rolling circle replication reporter systems
|
|
GB9624482D0
(en)
|
1995-12-18 |
1997-01-15 |
Zeneca Phaema S A |
Chemical compounds
|
|
DE69624081T2
(de)
|
1995-12-20 |
2003-06-12 |
Agouron Pharmaceuticals, Inc. |
Matrix-metalloprotease Inhibitoren
|
|
US5780462A
(en)
|
1995-12-27 |
1998-07-14 |
American Home Products Corporation |
Water soluble rapamycin esters
|
|
ATE217873T1
(de)
|
1996-01-23 |
2002-06-15 |
Novartis Erfind Verwalt Gmbh |
Pyrrolopyrimidinen und verfahren zu deren herstellung
|
|
JP3406763B2
(ja)
|
1996-01-30 |
2003-05-12 |
東レ・ダウコーニング・シリコーン株式会社 |
シリコーンゴム組成物
|
|
CH690773A5
(de)
|
1996-02-01 |
2001-01-15 |
Novartis Ag |
Pyrrolo(2,3-d)pyrimide und ihre Verwendung.
|
|
GB9603097D0
(en)
|
1996-02-14 |
1996-04-10 |
Zeneca Ltd |
Quinazoline compounds
|
|
GB9603095D0
(en)
|
1996-02-14 |
1996-04-10 |
Zeneca Ltd |
Quinazoline derivatives
|
|
US6291455B1
(en)
|
1996-03-05 |
2001-09-18 |
Zeneca Limited |
4-anilinoquinazoline derivatives
|
|
DE19608588A1
(de)
|
1996-03-06 |
1997-09-11 |
Thomae Gmbh Dr K |
Pyrimido [5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
DE19629652A1
(de)
|
1996-03-06 |
1998-01-29 |
Thomae Gmbh Dr K |
4-Amino-pyrimidin-Derivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
|
ES2203793T3
(es)
|
1996-03-15 |
2004-04-16 |
Novartis Ag |
N-7-heterociclil-pirrolo(2,3-d)pirimidinas y su empleo.
|
|
AU2324997A
(en)
|
1996-03-15 |
1997-10-01 |
Penn State Research Foundation, The |
Detection of extracellular tumor-associated nucleic acid in blood plasma or ser um using nucleic acid amplification assays
|
|
US5882644A
(en)
|
1996-03-22 |
1999-03-16 |
Protein Design Labs, Inc. |
Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
|
|
HU228446B1
(en)
|
1996-04-12 |
2013-03-28 |
Warner Lambert Co |
Kinazoline derivatives as irreversible inhibitors of protein-kinase, pharmaceutical compositions containing these compounds and use thereof
|
|
GB9607729D0
(en)
|
1996-04-13 |
1996-06-19 |
Zeneca Ltd |
Quinazoline derivatives
|
|
EP0907642B1
(en)
|
1996-06-24 |
2005-11-02 |
Pfizer Inc. |
Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
|
|
US6071935A
(en)
|
1996-06-27 |
2000-06-06 |
Pfizer Inc. |
Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors
|
|
CA2259157A1
(en)
|
1996-07-05 |
1998-01-15 |
Mount Sinai Hospital Corporation |
Oligomerized receptors which affect pathways regulated by transmembrane ligands for elk-related receptor tyrosine kinases
|
|
EP0818442A3
(en)
|
1996-07-12 |
1998-12-30 |
Pfizer Inc. |
Cyclic sulphone derivatives as inhibitors of metalloproteinases and of the production of tumour necrosis factor
|
|
US6258823B1
(en)
|
1996-07-12 |
2001-07-10 |
Ariad Pharmaceuticals, Inc. |
Materials and method for treating or preventing pathogenic fungal infection
|
|
US6171779B1
(en)
|
1996-07-12 |
2001-01-09 |
University Of Medicine & Dentistry Of New Jersey |
HMGI proteins in cancer
|
|
ID19609A
(id)
|
1996-07-13 |
1998-07-23 |
Glaxo Group Ltd |
Senyawa-senyawa heterosiklik
|
|
ES2191187T3
(es)
|
1996-07-13 |
2003-09-01 |
Glaxo Group Ltd |
Compuestos heteroaromaticos biciclicos como inhibidores de la proteina tirosin-quinasa.
|
|
HRP970371A2
(en)
|
1996-07-13 |
1998-08-31 |
Kathryn Jane Smith |
Heterocyclic compounds
|
|
EP0923585B1
(en)
|
1996-07-18 |
2002-05-08 |
Pfizer Inc. |
Phosphinate based inhibitors of matrix metalloproteases
|
|
WO1998007697A1
(en)
|
1996-08-23 |
1998-02-26 |
Pfizer Inc. |
Arylsulfonylamino hydroxamic acid derivatives
|
|
WO1998007726A1
(en)
|
1996-08-23 |
1998-02-26 |
Novartis Ag |
Substituted pyrrolopyrimidines and processes for their preparation
|
|
US5922730A
(en)
|
1996-09-09 |
1999-07-13 |
American Home Products Corporation |
Alkylated rapamycin derivatives
|
|
NZ330571A
(en)
|
1996-10-01 |
1999-10-28 |
Kyowa Hakko Kogyo Kk |
Nitrogenous heterocyclic compounds that may contain sulphur or oxygen
|
|
ID18494A
(id)
|
1996-10-02 |
1998-04-16 |
Novartis Ag |
Turunan pirazola leburan dan proses pembuatannya
|
|
US6251911B1
(en)
|
1996-10-02 |
2001-06-26 |
Novartis Ag |
Pyrimidine derivatives and processes for the preparation thereof
|
|
AU4779897A
(en)
|
1996-10-02 |
1998-04-24 |
Novartis Ag |
Fused pyrazole derivatives and processes for their preparation
|
|
EP0837063A1
(en)
|
1996-10-17 |
1998-04-22 |
Pfizer Inc. |
4-Aminoquinazoline derivatives
|
|
GB9621757D0
(en)
|
1996-10-18 |
1996-12-11 |
Ciba Geigy Ag |
Phenyl-substituted bicyclic heterocyclyl derivatives and their use
|
|
WO1998030566A1
(en)
|
1997-01-06 |
1998-07-16 |
Pfizer Inc. |
Cyclic sulfone derivatives
|
|
EP0977733B1
(en)
|
1997-02-03 |
2003-09-03 |
Pfizer Products Inc. |
Arylsulfonylamino hydroxamic acid derivatives
|
|
US5945422A
(en)
|
1997-02-05 |
1999-08-31 |
Warner-Lambert Company |
N-oxides of amino containing pyrido 2,3-D! pyrimidines
|
|
ES2301194T3
(es)
|
1997-02-05 |
2008-06-16 |
Warner-Lambert Company Llc |
Pirido 2,3-d pirimidinas y 4-aminopirimidinas como inhibidores de la proliferacion celular.
|
|
JP2000507975A
(ja)
|
1997-02-07 |
2000-06-27 |
ファイザー・インク |
Ｎ−ヒドロキシ−β−スルホニルプロピオンアミド誘導体類及びそれらのマトリックスメタロプロテイナーゼ阻害薬としての使用
|
|
EA002546B1
(ru)
|
1997-02-11 |
2002-06-27 |
Пфайзер Инк. |
Производные арилсульфонилгидроксамовой кислоты
|
|
EP0984930B1
(en)
|
1997-05-07 |
2005-04-06 |
Sugen, Inc. |
2-indolinone derivatives as modulators of protein kinase activity
|
|
US6251628B1
(en)
|
1997-05-20 |
2001-06-26 |
Ludwig Institute For Cancer Research |
Isolated nucleic acid molecules encoding Smad7
|
|
US6180632B1
(en)
|
1997-05-28 |
2001-01-30 |
Aventis Pharmaceuticals Products Inc. |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
|
|
US6159978A
(en)
|
1997-05-28 |
2000-12-12 |
Aventis Pharmaceuticals Product, Inc. |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
|
|
US6245760B1
(en)
|
1997-05-28 |
2001-06-12 |
Aventis Pharmaceuticals Products, Inc |
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
|
|
CA2291709A1
(en)
|
1997-05-30 |
1998-12-03 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
|
US6329375B1
(en)
|
1997-08-05 |
2001-12-11 |
Sugen, Inc. |
Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors
|
|
AU730248B2
(en)
|
1997-08-08 |
2001-03-01 |
Pfizer Products Inc. |
Aryloxyarylsulfonylamino hydroxamic acid derivatives
|
|
WO1999010349A1
(en)
|
1997-08-22 |
1999-03-04 |
Zeneca Limited |
Oxindolylquinazoline derivatives as angiogenesis inhibitors
|
|
US6015815A
(en)
|
1997-09-26 |
2000-01-18 |
Abbott Laboratories |
Tetrazole-containing rapamycin analogs with shortened half-lives
|
|
WO1999016755A1
(en)
|
1997-09-26 |
1999-04-08 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
|
TW557297B
(en)
|
1997-09-26 |
2003-10-11 |
Abbott Lab |
Rapamycin analogs having immunomodulatory activity, and pharmaceutical compositions containing same
|
|
CA2309690A1
(en)
|
1997-11-11 |
1999-05-20 |
Pfizer Products Inc. |
Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
|
|
US5932580A
(en)
|
1997-12-01 |
1999-08-03 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem |
PDGF receptor kinase inhibitory compounds their preparation and compositions
|
|
GB9725782D0
(en)
|
1997-12-05 |
1998-02-04 |
Pfizer Ltd |
Therapeutic agents
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
JPH11236333A
(ja)
|
1997-12-30 |
1999-08-31 |
Pfizer Prod Inc |
抗ガン剤として有用なイミダゾリン−４−オン誘導体
|
|
RS49779B
(sr)
|
1998-01-12 |
2008-06-05 |
Glaxo Group Limited, |
Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
|
|
GB9800575D0
(en)
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
|
GB9801690D0
(en)
|
1998-01-27 |
1998-03-25 |
Pfizer Ltd |
Therapeutic agents
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
PA8469401A1
(es)
|
1998-04-10 |
2000-05-24 |
Pfizer Prod Inc |
Derivados biciclicos del acido hidroxamico
|
|
PA8469501A1
(es)
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
|
KR20010071271A
(ko)
|
1998-05-15 |
2001-07-28 |
존 비. 랜디스 |
방사선 및 성장 인자 수용체 티로신 키나아제 억제제에의한 사람 종양의 치료법
|
|
EA005032B1
(ru)
|
1998-05-29 |
2004-10-28 |
Сьюджен, Инк. |
Пирролзамещенные 2-индолиноны (варианты), фармацевтическая композиция (варианты), способ модулирования каталитической активности протеинкиназы, способ лечения или профилактики нарушения в организме, связанного с протеинкиназой
|
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
|
US7342108B2
(en)
|
1998-06-25 |
2008-03-11 |
The General Hospital Corporation |
De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof
|
|
US7368551B2
(en)
|
1998-06-25 |
2008-05-06 |
The General Hospital Corporation |
De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof
|
|
US6566131B1
(en)
|
2000-10-04 |
2003-05-20 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of Smad6 expression
|
|
US6015809A
(en)
|
1998-08-17 |
2000-01-18 |
American Home Products Corporation |
Photocyclized rapamycin
|
|
DE69923849T2
(de)
|
1998-08-27 |
2006-01-12 |
Pfizer Products Inc., Groton |
Quinolin-2-on-derivate verwendbar als antikrebsmittel
|
|
TR200101343T2
(tr)
|
1998-08-27 |
2001-09-21 |
Pfizer Products Inc. |
Kansere karşı kullanılan maddeler olarak alkinil-ikame edilmiş kinolin-2-on türevleri
|
|
AU5914299A
(en)
|
1998-09-11 |
2000-04-03 |
Eli Lilly And Company |
Antagonists of fibroblast growth factor
|
|
CA2344249A1
(en)
|
1998-09-18 |
2000-03-30 |
Basf Aktiengesellschaft |
Pyrrolopyrimidines as protein kinase inhibitors
|
|
US6410323B1
(en)
|
1999-08-31 |
2002-06-25 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of human Rho family gene expression
|
|
DK1004578T3
(da)
|
1998-11-05 |
2004-06-28 |
Pfizer Prod Inc |
5-oxo-pyrrolidin-2-carboxylsyrehydroxamidderivater
|
|
EP1006113A1
(en)
|
1998-12-02 |
2000-06-07 |
Pfizer Products Inc. |
Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth
|
|
US6107091A
(en)
|
1998-12-03 |
2000-08-22 |
Isis Pharmaceuticals Inc. |
Antisense inhibition of G-alpha-16 expression
|
|
US5981732A
(en)
|
1998-12-04 |
1999-11-09 |
Isis Pharmaceuticals Inc. |
Antisense modulation of G-alpha-13 expression
|
|
US6337338B1
(en)
|
1998-12-15 |
2002-01-08 |
Telik, Inc. |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists
|
|
US6682736B1
(en)
|
1998-12-23 |
2004-01-27 |
Abgenix, Inc. |
Human monoclonal antibodies to CTLA-4
|
|
UA71945C2
(en)
|
1999-01-27 |
2005-01-17 |
Pfizer Prod Inc |
Substituted bicyclic derivatives being used as anticancer agents
|
|
JP3270834B2
(ja)
|
1999-01-27 |
2002-04-02 |
ファイザー・プロダクツ・インク |
抗がん剤として有用なヘテロ芳香族二環式誘導体
|
|
US6656728B1
(en)
|
1999-02-08 |
2003-12-02 |
Chiron Corporation |
Fibroblast growth factor receptor-immunoglobulin fusion
|
|
SK11002001A3
(sk)
|
1999-02-11 |
2002-05-09 |
Pfizer Products Inc. |
Heteroarylom substituované chinolin-2-ónové deriváty použiteľné ako protinádorové prostriedky
|
|
US6586447B1
(en)
|
1999-04-01 |
2003-07-01 |
Pfizer Inc |
3,3-disubstituted-oxindole derivatives useful as anticancer agents
|
|
US6046321A
(en)
|
1999-04-09 |
2000-04-04 |
Isis Pharmaceuticals Inc. |
Antisense modulation of G-alpha-i1 expression
|
|
DE60026297T2
(de)
|
1999-05-21 |
2006-11-02 |
Bristol-Myers Squibb Co. |
Pyrrolotriazin kinasehemmer
|
|
ES2161655B1
(es)
|
1999-07-01 |
2002-06-01 |
Consejo Superior Investigacion |
Procedimiento para determinar la capacidad invasiva y metastasica de un tumor epitelial mediante el uso de snail.
|
|
US6455525B1
(en)
|
1999-11-04 |
2002-09-24 |
Cephalon, Inc. |
Heterocyclic substituted pyrazolones
|
|
US6358954B1
(en)
|
1999-11-09 |
2002-03-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
|
|
UA74803C2
(uk)
|
1999-11-11 |
2006-02-15 |
Осі Фармасьютікалз, Інк. |
Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
|
|
GB9927444D0
(en)
|
1999-11-19 |
2000-01-19 |
Cancer Res Campaign Tech |
Inhibiting gene expression
|
|
PT1106612E
(pt)
|
1999-11-30 |
2004-06-30 |
Pfizer Prod Inc |
Derivados de quinolina uteis para inibir a farnesil-proteina-transferase
|
|
UA75055C2
(uk)
|
1999-11-30 |
2006-03-15 |
Пфайзер Продактс Інк. |
Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі
|
|
US6448086B1
(en)
|
2000-01-18 |
2002-09-10 |
Diagnostic Systems Laboratories, Inc. |
Insulin-like growth factor system and cancer
|
|
HN2000000266A
(es)
|
2000-01-21 |
2001-05-21 |
Pfizer Prod Inc |
Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
|
|
AU2001248352A1
(en)
|
2000-03-15 |
2001-09-24 |
Epigenomics Ag |
Diagnosis of diseases associated with the cell cycle
|
|
EP1272630A2
(en)
|
2000-03-16 |
2003-01-08 |
Genetica, Inc. |
Methods and compositions for rna interference
|
|
US7348162B2
(en)
|
2000-03-22 |
2008-03-25 |
Amgen Inc. |
Nucleic acids encoding fibroblast growth factor receptor-like proteins and uses thereof
|
|
TWI310684B
(en)
|
2000-03-27 |
2009-06-11 |
Bristol Myers Squibb Co |
Synergistic pharmaceutical kits for treating cancer
|
|
WO2001072751A1
(en)
|
2000-03-29 |
2001-10-04 |
Knoll Gesellschaft Mit Beschraenkter Haftung |
Pyrrolopyrimidines as tyrosine kinase inhibitors
|
|
US6365354B1
(en)
|
2000-07-31 |
2002-04-02 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of lysophospholipase I expression
|
|
CA2417942C
(en)
|
2000-08-04 |
2010-06-29 |
Warner-Lambert Company |
2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones
|
|
US6566135B1
(en)
|
2000-10-04 |
2003-05-20 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of caspase 6 expression
|
|
US20020169562A1
(en)
|
2001-01-29 |
2002-11-14 |
Gregory Stephanopoulos |
Defining biological states and related genes, proteins and patterns
|
|
AR035885A1
(es)
|
2001-05-14 |
2004-07-21 |
Novartis Ag |
Derivados de 4-amino-5-fenil-7-ciclobutilpirrolo (2,3-d)pirimidina, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la preparacion de una composicion farmaceutica
|
|
US20030053995A1
(en)
|
2001-06-15 |
2003-03-20 |
Mien-Chie Hung |
Methods and compositions for inhibiting EGF receptor activity
|
|
SE0102168D0
(sv)
|
2001-06-19 |
2001-06-19 |
Karolinska Innovations Ab |
New use and new compounds
|
|
AU2002329540A1
(en)
|
2001-06-20 |
2003-01-02 |
Morphosys Ag |
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
|
|
GB0119249D0
(en)
|
2001-08-07 |
2001-10-03 |
Novartis Ag |
Organic compounds
|
|
FR2828601B1
(fr)
|
2001-08-10 |
2003-11-07 |
Iroc Technologies |
Ensemble de circuits electroniques comportant des moyens de decontamination de parties contaminees par des erreurs
|
|
US6939874B2
(en)
|
2001-08-22 |
2005-09-06 |
Amgen Inc. |
Substituted pyrimidinyl derivatives and methods of use
|
|
US7115617B2
(en)
|
2001-08-22 |
2006-10-03 |
Amgen Inc. |
Amino-substituted pyrimidinyl derivatives and methods of use
|
|
IL160915A0
(en)
|
2001-09-19 |
2004-08-31 |
Aventis Pharma Sa |
Indolizines inhibiting kinase proteins
|
|
EP1436329A4
(en)
|
2001-09-20 |
2005-04-27 |
Alexion Pharma Inc |
ANTI-PDGF ANTIBODIES AND METHODS FOR PRODUCING FOCUSED ANTIBODIES
|
|
WO2003035614A2
(en)
|
2001-10-25 |
2003-05-01 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
WO2003035619A1
(en)
|
2001-10-25 |
2003-05-01 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
WO2003035616A2
(en)
|
2001-10-25 |
2003-05-01 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
WO2003035615A2
(en)
|
2001-10-25 |
2003-05-01 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US20070237770A1
(en)
|
2001-11-30 |
2007-10-11 |
Albert Lai |
Novel compositions and methods in cancer
|
|
SE0104140D0
(sv)
|
2001-12-07 |
2001-12-07 |
Astrazeneca Ab |
Novel Compounds
|
|
AU2002358279A1
(en)
|
2001-12-21 |
2003-07-30 |
Arcturus Engineering, Inc. |
Biomarkers for breast cancer
|
|
US20030144260A1
(en)
|
2002-01-03 |
2003-07-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Heterocyclic compounds, method of developing new drug leads and combinatorial libraries used in such method
|
|
JP2005532036A
(ja)
|
2002-01-09 |
2005-10-27 |
理化学研究所 |
癌プロフィール
|
|
US7241444B2
(en)
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
|
JP2005523688A
(ja)
|
2002-01-18 |
2005-08-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
タンパク質チロシンキナーゼおよび／またはタンパク質チロシンキナーゼ経路と相互作用する化合物の活性を予測するためのポリヌクレオチドおよびポリペプチドの同定
|
|
US7553485B2
(en)
|
2002-01-18 |
2009-06-30 |
Pierre Fabre Medicament |
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
|
|
ES2283744T3
(es)
|
2002-02-14 |
2007-11-01 |
Dana-Farber Cancer Institute, Inc. |
Metodos y composiciones para el tratamiento de condiciones hiperproliferativas.
|
|
CA2992643C
(en)
|
2002-03-13 |
2019-06-18 |
Genomic Health, Inc. |
Gene expression profiling in biopsied tumor tissues
|
|
GB0206215D0
(en)
|
2002-03-15 |
2002-05-01 |
Novartis Ag |
Organic compounds
|
|
US20040018528A1
(en)
|
2002-05-17 |
2004-01-29 |
Sugen, Inc. |
Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
|
|
US7217796B2
(en)
|
2002-05-24 |
2007-05-15 |
Schering Corporation |
Neutralizing human anti-IGFR antibody
|
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
|
KR20050037510A
(ko)
|
2002-06-05 |
2005-04-22 |
세다르스-신나이 메디칼 센터 |
키나제 억제제를 사용하는 암 치료 방법
|
|
US8034904B2
(en)
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
|
AU2003251597A1
(en)
|
2002-06-19 |
2004-01-06 |
Abgenix, Inc. |
Method for predicting response to epidermal growth factor receptor-directed therapy
|
|
TW200401638A
(en)
|
2002-06-20 |
2004-02-01 |
Bristol Myers Squibb Co |
Heterocyclic inhibitors of kinases
|
|
GB0215844D0
(en)
|
2002-07-09 |
2002-08-14 |
Novartis Ag |
Organic compounds
|
|
US20040063120A1
(en)
|
2002-07-10 |
2004-04-01 |
The Regents Of The University Of Michigan |
Expression profile of lung cancer
|
|
TWI329112B
(en)
|
2002-07-19 |
2010-08-21 |
Bristol Myers Squibb Co |
Novel inhibitors of kinases
|
|
WO2004013145A1
(en)
|
2002-08-02 |
2004-02-12 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
US7084270B2
(en)
|
2002-08-14 |
2006-08-01 |
Hoffman-La Roche Inc. |
Pyrimido compounds having antiproliferative activity
|
|
US20040209930A1
(en)
|
2002-10-02 |
2004-10-21 |
Carboni Joan M. |
Synergistic methods and compositions for treating cancer
|
|
TW200501960A
(en)
|
2002-10-02 |
2005-01-16 |
Bristol Myers Squibb Co |
Synergistic kits and compositions for treating cancer
|
|
US7112676B2
(en)
|
2002-11-04 |
2006-09-26 |
Hoffmann-La Roche Inc. |
Pyrimido compounds having antiproliferative activity
|
|
AU2003295598B2
(en)
|
2002-11-15 |
2009-12-24 |
Genomic Health, Inc. |
Gene expression profiling of EGFR positive cancer
|
|
BR0316375A
(pt)
|
2002-11-18 |
2005-10-04 |
Hoffmann La Roche |
Diazinopirimidinas
|
|
WO2004048516A2
(en)
|
2002-11-22 |
2004-06-10 |
North Shore-Long Island Jewish Research Institute |
Elf3 gene compositions and methods
|
|
AU2003300899A1
(en)
|
2002-12-12 |
2004-06-30 |
Oncotech, Inc. |
Genes related to sensitivity and resistance to chemotherapeutic drug treatment
|
|
TWI299664B
(en)
|
2003-01-06 |
2008-08-11 |
Osi Pharm Inc |
(2-carboxamido)(3-amino)thiophene compounds
|
|
US7696225B2
(en)
|
2003-01-06 |
2010-04-13 |
Osi Pharmaceuticals, Inc. |
(2-carboxamido)(3-Amino) thiophene compounds
|
|
JP2007520995A
(ja)
|
2003-01-08 |
2007-08-02 |
ブリストル−マイヤーズ スクイブ カンパニー |
上皮増殖因子受容体モデュレーターに対する感受性を決定するためのバイオマーカーおよび方法
|
|
WO2004065602A1
(es)
|
2003-01-17 |
2004-08-05 |
Universidad Autónoma de Madrid |
Procedimiento para identificar la transición epitelio-mesenquimal de células mesoteliales (temcm) e identificar compuestos moduladores de temcm, composiciones farmacéuticas y su uso en el diagnóstico y tratamiento de enfermedades que cursan con temcm
|
|
CA2515096A1
(en)
|
2003-02-06 |
2004-08-26 |
Genomic Health, Inc. |
Gene expression markers for response to egfr inhibitor drugs
|
|
US7253166B2
(en)
|
2003-04-22 |
2007-08-07 |
Irm Llc |
6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells
|
|
EP1636380A2
(en)
|
2003-05-30 |
2006-03-22 |
Genomic Health, Inc. |
Gene expression markers for response to egfr inhibitor drugs
|
|
US20060078941A1
(en)
|
2003-06-09 |
2006-04-13 |
Santin Alessandro D |
Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
|
|
US20070092881A1
(en)
|
2003-07-10 |
2007-04-26 |
Central Institute For Experimental Animals |
Gene markers of tumor metastasis
|
|
US7526387B2
(en)
|
2003-07-10 |
2009-04-28 |
Genomic Health, Inc. |
Expression profile algorithm and test for cancer prognosis
|
|
MXPA06001098A
(es)
|
2003-07-29 |
2006-04-24 |
Irm Llc |
Compuestos y composiciones utiles como inhibidores de proteina cinasa.
|
|
WO2005017493A2
(en)
|
2003-08-15 |
2005-02-24 |
Smithkline Beecham Corporation |
Biomarkers in cancer
|
|
DE602004020073D1
(de)
|
2003-08-21 |
2009-04-30 |
Osi Pharm Inc |
3-substituierte imidazopyridinderivate als c-kit-inhibitoren
|
|
EP1664032B1
(en)
|
2003-08-21 |
2008-11-05 |
OSI Pharmaceuticals, Inc. |
N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors
|
|
AU2004268949A1
(en)
|
2003-08-21 |
2005-03-10 |
Osi Pharmaceuticals, Inc. |
N-substituted benzimidazolyl C-kit inhibitors
|
|
EP1980629A3
(en)
|
2003-08-28 |
2008-12-17 |
Ipsogen |
Identification of an erbb2 gene expression signature in breast cancers
|
|
DE10342503A1
(de)
|
2003-09-12 |
2005-04-14 |
Merck Patent Gmbh |
Benzyl-Benzimidazolylderivate
|
|
GB0321694D0
(en)
|
2003-09-16 |
2003-10-15 |
Ark Therapeutics Ltd |
Genes and their therapeutic use
|
|
KR100872204B1
(ko)
|
2003-10-15 |
2008-12-09 |
오에스아이 파마슈티컬스, 인코포레이티드 |
이미다조피라진 티로신 키나제 억제제
|
|
CA2542656A1
(en)
|
2003-10-16 |
2005-05-06 |
Genomic Health, Inc. |
Qrt-pcr assay system for gene expression profiling
|
|
PE20050928A1
(es)
|
2003-11-21 |
2005-11-08 |
Schering Corp |
Combinaciones terapeuticas de anticuerpo anti-igfr1
|
|
DE10356579A1
(de)
|
2003-12-04 |
2005-07-07 |
Merck Patent Gmbh |
Aminderivate
|
|
JP5192632B2
(ja)
|
2003-12-12 |
2013-05-08 |
愛知県 |
肺癌組織中の遺伝子発現強度を識別する方法
|
|
CA2550245A1
(en)
|
2003-12-19 |
2005-07-21 |
Five Prime Therapeutics, Inc. |
Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention
|
|
JP2007537717A
(ja)
|
2004-01-07 |
2007-12-27 |
ブリストル−マイヤーズ スクイブ カンパニー |
上皮増殖因子受容体モデュレーターに対する感受性を決定するためのバイオマーカーおよび方法
|
|
US20080113874A1
(en)
|
2004-01-23 |
2008-05-15 |
The Regents Of The University Of Colorado |
Gefitinib sensitivity-related gene expression and products and methods related thereto
|
|
US8017321B2
(en)
|
2004-01-23 |
2011-09-13 |
The Regents Of The University Of Colorado, A Body Corporate |
Gefitinib sensitivity-related gene expression and products and methods related thereto
|
|
WO2005085860A2
(en)
|
2004-02-27 |
2005-09-15 |
Institut Curie |
New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
|
|
CA2561111A1
(en)
|
2004-03-26 |
2005-10-13 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators in non-small cell lung cancer
|
|
WO2005099363A2
(en)
|
2004-03-26 |
2005-10-27 |
Whitehead Institute For Biomedical Research |
Methods of diagnosing, preventing and treating cancer metastasis
|
|
US20060019268A1
(en)
|
2004-03-26 |
2006-01-26 |
Research Development Foundation |
Molecular markers of cisplatin resistance in cancer and uses thereof
|
|
TWI378934B
(en)
|
2004-04-02 |
2012-12-11 |
Osi Pharm Inc |
6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
|
|
US20050256154A1
(en)
|
2004-05-04 |
2005-11-17 |
Kin-Chun Luk |
4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid amides
|
|
WO2005107803A2
(en)
|
2004-05-06 |
2005-11-17 |
Vernalis Plc |
Methods of determining the prognosis and treatment of subjects with lung cancer
|
|
DK2537942T3
(en)
|
2004-05-21 |
2015-12-14 |
Trustees Of The University Of Arkansas System Board Of |
Use of genudtryksprofilering to predict survival in cancer patients
|
|
US7741035B2
(en)
|
2004-05-21 |
2010-06-22 |
Board Of Trustees Of The University Of Arkansas |
Use of gene expression profiling to predict survival in cancer patient
|
|
WO2005117553A2
(en)
|
2004-05-27 |
2005-12-15 |
The Regents Of The University Of Colorado |
Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients
|
|
US7102002B2
(en)
|
2004-06-16 |
2006-09-05 |
Bristol-Myers Squibb Company |
Pyrrolotriazine kinase inhibitors
|
|
KR20070036130A
(ko)
|
2004-07-16 |
2007-04-02 |
화이자 프로덕츠 인코포레이티드 |
항-아이지에프-1알 항체를 사용하는 비-혈액학적악성종양에 대한 조합 치료
|
|
FR2875601B1
(fr)
|
2004-09-17 |
2007-04-13 |
Genome Express S A Sa |
Vimentine phosphorylee comme marqueur de l'agressivite et/ou l'invasivite des tumeurs
|
|
WO2006042599A1
(de)
|
2004-10-13 |
2006-04-27 |
Merck Patent Gmbh |
Phenylharnstoffderivate als hemmstoffe von tyrosinkinasen zur behandlung von tumorerkrankungen
|
|
JP2008518207A
(ja)
|
2004-10-21 |
2008-05-29 |
ザ ペン ステート リサーチ ファウンデーション |
Ｅｐｈ受容体腫瘍バイオマーカー
|
|
US7151176B2
(en)
|
2004-10-21 |
2006-12-19 |
Bristol-Myers Squibb Company |
Pyrrolotriazine compounds
|
|
DE102004054216A1
(de)
|
2004-11-10 |
2006-05-11 |
Merck Patent Gmbh |
Substituierte 4-Amino-pyridopyrimidinone
|
|
DE102004054215A1
(de)
|
2004-11-10 |
2006-05-11 |
Merck Patent Gmbh |
Pyridopyrimidinonderivate
|
|
EP2283831A3
(en)
|
2004-12-03 |
2013-10-23 |
Merck Sharp & Dohme Corp. |
Biomakers for pre-selection of patients for anti-IGF1R therapy
|
|
US7666595B2
(en)
|
2005-02-25 |
2010-02-23 |
The Brigham And Women's Hospital, Inc. |
Biomarkers for predicting prostate cancer progression
|
|
DE102005011058A1
(de)
|
2005-03-10 |
2006-09-14 |
Merck Patent Gmbh |
Substituierte Tetrahydro-pyrrolo-chinolinderivate
|
|
US20080234265A1
(en)
|
2005-03-11 |
2008-09-25 |
The Regents Of The University Of Colorado |
Histone Deacetylase Inhibitors Sensitize Cancer Cells to Epidermal Growth Factor Inhibitors
|
|
CA2601157A1
(en)
|
2005-03-16 |
2006-09-28 |
Osi Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
|
|
US8383357B2
(en)
*
|
2005-03-16 |
2013-02-26 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
|
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
|
DE102005017259A1
(de)
|
2005-04-14 |
2006-10-19 |
Merck Patent Gmbh |
Purinderivate
|
|
WO2006112479A1
(ja)
|
2005-04-19 |
2006-10-26 |
Kyowa Hakko Kogyo Co., Ltd. |
含窒素複素環化合物
|
|
US20090061422A1
(en)
|
2005-04-19 |
2009-03-05 |
Linke Steven P |
Diagnostic markers of breast cancer treatment and progression and methods of use thereof
|
|
US20090118175A1
(en)
|
2005-05-06 |
2009-05-07 |
Macina Roberto A |
Compositions and Methods for Detection, Prognosis and Treatment of Breast Cancer
|
|
WO2006134989A1
(ja)
|
2005-06-15 |
2006-12-21 |
Kyowa Hakko Kogyo Co., Ltd. |
含窒素複素環化合物
|
|
PL1913157T5
(pl)
|
2005-06-28 |
2017-09-29 |
Genentech Inc |
Mutacje EGFR i KRAS do prognozowania reakcji pacjenta na leczenie inhibitorem EGFR
|
|
WO2007013946A2
(en)
|
2005-07-20 |
2007-02-01 |
University Of South Florida |
Method of predicting responsiveness to chemotherapy and selecting treatments
|
|
GB0515026D0
(en)
|
2005-07-21 |
2005-08-31 |
Novartis Ag |
Organic compounds
|
|
EP1910542B1
(en)
|
2005-07-22 |
2009-12-02 |
Five Prime Therapeutics, Inc. |
Compositions and methods of treating disease with fgfr fusion proteins
|
|
US20090155786A1
(en)
|
2005-08-15 |
2009-06-18 |
President And Fellows Of Harvard College |
Compositions and methods for detecting markers of cancer
|
|
JP2009504692A
(ja)
|
2005-08-16 |
2009-02-05 |
エフ．ホフマン−ラ ロシュ アーゲー |
新規４−アミノ−チエノ［３，２−ｃ］ピリジン−７−カルボン酸アミド
|
|
EP1929306A4
(en)
|
2005-09-01 |
2009-11-11 |
Precision Therapeutics Inc |
CHEMOSENSIBLE ASSAYS, THE TUMOR CELLS WITH PERSISTENT PHENOTYPICAL CHARACTERISTICS
|
|
AU2006292278B2
(en)
|
2005-09-20 |
2012-03-08 |
Osi Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
|
US20070161018A1
(en)
|
2005-11-04 |
2007-07-12 |
Johji Inazawa |
Method for detecting cancer and a method for suppressing cancer
|
|
US8445198B2
(en)
|
2005-12-01 |
2013-05-21 |
Medical Prognosis Institute |
Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
WO2007067500A2
(en)
|
2005-12-05 |
2007-06-14 |
Genomic Health, Inc. |
Predictors of patient response to treatment with egfr inhibitors
|
|
JP2009520028A
(ja)
|
2005-12-19 |
2009-05-21 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
Ｉｇｆｒ抑制剤および抗癌剤の併用
|
|
JP2007175021A
(ja)
|
2005-12-28 |
2007-07-12 |
Sysmex Corp |
大腸がんのリンパ節転移マーカー
|
|
WO2008121102A2
(en)
|
2006-02-21 |
2008-10-09 |
The Regents Of The University Of Michigan |
Hedgehog signaling pathway antagonist cancer treatment
|
|
US20070218512A1
(en)
|
2006-02-28 |
2007-09-20 |
Alex Strongin |
Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management
|
|
US20070231822A1
(en)
|
2006-02-28 |
2007-10-04 |
Michael Mitas |
Methods for the detection and treatment of cancer
|
|
WO2007103541A2
(en)
|
2006-03-09 |
2007-09-13 |
The Trustees Of Boston University |
Diagnostic and prognostic methods for lung disorders using gene expression profiles from nose epithelial cells
|
|
US7612178B2
(en)
|
2006-03-28 |
2009-11-03 |
Biogen Idec Ma Inc |
Anti-IGF-1R antibodies and uses thereof
|
|
US7812143B2
(en)
|
2006-03-31 |
2010-10-12 |
Memorial Sloan-Kettering Cancer Center |
Biomarkers for cancer treatment
|
|
MX2008015425A
(es)
|
2006-06-02 |
2008-12-12 |
Pfizer Prod Inc |
Ensayo de celulas tumorales circulantes.
|
|
US20080026481A1
(en)
|
2006-06-16 |
2008-01-31 |
Michael Mitas |
Molecular based two-marker assays that predict outcome of adenocarcinoma patients
|
|
US20080112888A1
(en)
|
2006-06-30 |
2008-05-15 |
Schering Corporation |
Igfbp2 biomarker
|
|
US20080167532A1
(en)
|
2006-10-13 |
2008-07-10 |
Mayo Foundation For Medical Education And Research |
Assessing cancer treatment responsiveness
|
|
US7622456B2
(en)
|
2006-11-06 |
2009-11-24 |
Non-Profit Organization Chang Gung Memorial Hospital |
Method on clinical applications in head neck cancer by using DSG3 molecule for predicting malignant degree of cancer, serving as a molecular target and using RNA jamming sequence on inhibition-specific of DSG3 expression
|
|
DK2087139T3
(en)
|
2006-11-07 |
2017-02-13 |
Univ Arkansas |
Gene expression profiling-based identification of high-risk multiple myeloma genomic signatures
|
|
WO2008070460A2
(en)
|
2006-11-27 |
2008-06-12 |
The Regents Of The University Of California |
The use of soluble e-cadherin as a novel serum marker
|
|
WO2008073290A1
(en)
|
2006-12-08 |
2008-06-19 |
The Board Of Trustees Of The University Of Arkansas |
Tp53 gene expression and uses thereof
|
|
EP2993473A1
(en)
|
2007-01-30 |
2016-03-09 |
Pharmacyclics, Inc. |
Methods for determining cancer resistance to histone deacetylase inhibitors
|
|
ATE530907T1
(de)
|
2007-02-27 |
2011-11-15 |
Hoffmann La Roche |
Verfahren zur beurteilung der hemmungsaktivität von antikörpern gegen insulinartigen wachstumsfaktor-1-rezeptor
|
|
US20100166747A1
(en)
|
2007-03-02 |
2010-07-01 |
Beltran Pedro J |
Methods and compositions for treating tumor diseases
|
|
WO2008115470A2
(en)
|
2007-03-16 |
2008-09-25 |
East Carolina University |
Hox-gene expression as a biomarker for igf-1r therapeutics
|
|
JP5240739B2
(ja)
|
2007-04-13 |
2013-07-17 |
オーエスアイ・フアーマシユーテイカルズ・エル・エル・シー |
キナーゼ阻害剤に対する抗癌応答を予測する生物学的マーカー
|
|
EP2145021A2
(en)
|
2007-05-17 |
2010-01-20 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators
|
|
WO2009023172A2
(en)
|
2007-08-09 |
2009-02-19 |
The Johns Hopkins University |
Predictions of responsiveness to egfr inhibitors
|
|
US8622606B2
(en)
|
2007-09-25 |
2014-01-07 |
State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University |
Micro-channels, micro-mixers, and micro-reactors
|
|
JP2010540960A
(ja)
|
2007-10-03 |
2010-12-24 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
インスリン様成長因子−１受容体キナーゼ阻害剤に対する抗癌反応を予測する生物学的マーカー
|
|
JP2011501660A
(ja)
*
|
2007-10-03 |
2011-01-13 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
インスリン様成長因子−１受容体キナーゼ阻害剤に対する抗癌反応を予測する生物学的マーカー
|
|
WO2009049228A2
(en)
|
2007-10-10 |
2009-04-16 |
The Regents Of The University Of Michigan |
Compositions and methods for assessing disorders
|
|
WO2009075799A2
(en)
*
|
2007-12-05 |
2009-06-18 |
The Wistar Institute Of Anatomy And Biology |
Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells
|
|
WO2009099982A1
(en)
|
2008-02-04 |
2009-08-13 |
Osi Pharmaceuticals, Inc. |
2-aminopyridine kinase inhibitors
|
|
US7998688B2
(en)
*
|
2008-03-07 |
2011-08-16 |
OSI Pharmaceuticals, LLC |
Inhibition of EMT induction in tumor cells by anti-cancer agents
|
|
US20110262453A1
(en)
|
2008-08-20 |
2011-10-27 |
Witta Samir E |
Markers for Assessing the Susceptibility of Cancer to IGF-1R Treatment
|
|
US20120142028A1
(en)
|
2009-04-17 |
2012-06-07 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
|
|
US20110143960A1
(en)
|
2009-12-10 |
2011-06-16 |
Labarbera Daniel V |
3d-models for high-throughput screening drug discovery and development
|
|
US20140030255A1
(en)
*
|
2010-11-03 |
2014-01-30 |
Merck Sharp & Dohme Corp. |
Methods of predicting cancer cell response to therapeutic agents
|